Crinetics Pharmaceuticals, Inc. is a high-risk pharmaceutical company based in the United States of America. With a Risk Rating Score of 31.9, Crinetics Pharmaceuticals, Inc. is dedicated to developing innovative treatments for rare endocrine diseases and tumors. Their focus on ESG principles sets them apart in the industry.